Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke S Howard

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Congestive Heart Failure (Greenwich, Conn.)|November 25, 2010
Reduced confounding by impaired ventilatory function with oxygen uptake efficiency slope and VE/VCO2 slope rather than peak oxygen consumption to assess exercise physiology in suspected heart failureAnthony J Barron, Katharine I Medlow, Alberto Giannoni, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|April 23, 2010
Right ventricular function in patients with pulmonary hypertension; the value of myocardial performance index measured by tissue Doppler imagingInês Zimbarra Cabrita, Cristina Ruisanchez, David Dawson, et al.
Chest|September 11, 2022
Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE)Luke S Howard, Stephan Rosenkranz, Robert P Frantz, et al.
Thorax|April 12, 2022
BTS clinical statement for the assessment and management of respiratory problems in athletic individualsJames H Hull, Paul Burns, Jane Carre, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 16, 2016
Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertensionAthanasios Charalampopoulos, J Simon R Gibbs, Rachel J Davies, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Treatment goals of pulmonary hypertension]Vallerie V McLaughlin, Sean Patrick Gaine, Luke S Howard, et al.
Pulmonary Circulation|January 23, 2015
Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factorsAthanasios Charalampopoulos, Luke S Howard, Ioanna Tzoulaki, et al.
Journal of the American College of Cardiology|December 21, 2013
Treatment goals of pulmonary hypertensionVallerie V McLaughlin, Sean Patrick Gaine, Luke S Howard, et al.
The European Respiratory Journal|April 10, 2025
Prognostic value of cardiopulmonary exercise testing in pulmonary arterial hypertensionAndrea Baccelli, Rocco F Rinaldo, Gulammehdi Haji, et al.
Pulmonary Therapy|November 9, 2024
Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label ExtensionNick H Kim, Andrea M D'Armini, Luke S Howard, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Congestive Heart Failure (Greenwich, Conn.)|November 25, 2010
Reduced confounding by impaired ventilatory function with oxygen uptake efficiency slope and VE/VCO2 slope rather than peak oxygen consumption to assess exercise physiology in suspected heart failureAnthony J Barron, Katharine I Medlow, Alberto Giannoni, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|April 23, 2010
Right ventricular function in patients with pulmonary hypertension; the value of myocardial performance index measured by tissue Doppler imagingInês Zimbarra Cabrita, Cristina Ruisanchez, David Dawson, et al.
Chest|September 11, 2022
Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE)Luke S Howard, Stephan Rosenkranz, Robert P Frantz, et al.
Thorax|April 12, 2022
BTS clinical statement for the assessment and management of respiratory problems in athletic individualsJames H Hull, Paul Burns, Jane Carre, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 16, 2016
Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertensionAthanasios Charalampopoulos, J Simon R Gibbs, Rachel J Davies, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Treatment goals of pulmonary hypertension]Vallerie V McLaughlin, Sean Patrick Gaine, Luke S Howard, et al.
Pulmonary Circulation|January 23, 2015
Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factorsAthanasios Charalampopoulos, Luke S Howard, Ioanna Tzoulaki, et al.
Journal of the American College of Cardiology|December 21, 2013
Treatment goals of pulmonary hypertensionVallerie V McLaughlin, Sean Patrick Gaine, Luke S Howard, et al.
The European Respiratory Journal|April 10, 2025
Prognostic value of cardiopulmonary exercise testing in pulmonary arterial hypertensionAndrea Baccelli, Rocco F Rinaldo, Gulammehdi Haji, et al.
Pulmonary Therapy|November 9, 2024
Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label ExtensionNick H Kim, Andrea M D'Armini, Luke S Howard, et al.
Pageof 12